glp 1 lower blood pressure GLP-1 drugs tied to risks in certain patients, study finds GLP-1 Agonists: Using Semaglutide, Tirzepatide,

GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice

*Correspondence: Tams Molnr, [email protected] These authors have contributed equally to this work This article was submitted to Nutrition and Microbes, a section of the journal Frontiers in Nutrition Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Arroyave Hernandez CM, Echavarra Pinto M, and Hernndez Montiel HL

10.1034/j.1399-5618.1999.010204.x 79 HannunY